These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11164689)

  • 21. Triazolam and zolpidem: effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    Bickel WK; Oliveto AH; Kamien JB; Higgins ST; Hughes JR
    J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
    Griffiths RR; Sannerud CA; Ator NA; Brady JV
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1199-208. PubMed ID: 1312162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
    Kohut SJ; Ator NA
    Pharmacol Biochem Behav; 2008 Jul; 90(1):65-73. PubMed ID: 18395780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women.
    Babalonis S; Emurian CS; Martin CA; Lile JA; Kelly TH
    Drug Alcohol Depend; 2008 Apr; 94(1-3):276-80. PubMed ID: 18178039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
    Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
    Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selectivity in generalization to GABAergic drugs in midazolam-trained baboons.
    Ator NA
    Pharmacol Biochem Behav; 2003 May; 75(2):435-45. PubMed ID: 12873636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminative stimulus properties of alprazolam.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Psychopharmacology (Berl); 2000 Feb; 148(2):146-52. PubMed ID: 10663429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
    Mirza NR; Rodgers RJ; Mathiasen LS
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.
    McMahon LR; Gerak LR; Carter L; Ma C; Cook JM; France CP
    J Pharmacol Exp Ther; 2002 Feb; 300(2):505-12. PubMed ID: 11805210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of daytime administration of zolpidem versus triazolam on memory.
    Wesensten NJ; Balkin TJ; Belenky GL
    Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
    J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
    Balkin TJ; O'Donnell VM; Wesensten N; McCann U; Belenky G
    Psychopharmacology (Berl); 1992; 107(1):83-8. PubMed ID: 1589566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
    Ator NA
    Drug Alcohol Depend; 2000 Dec; 61(1):55-68. PubMed ID: 11064184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure.
    Oliveto AH; Bickel WK; Kamien JB; Hughes JR; Higgins ST
    Psychopharmacology (Berl); 1994 Apr; 114(3):417-23. PubMed ID: 7531852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys.
    Rowlett JK; Woolverton WL
    Drug Alcohol Depend; 2001 Feb; 61(3):229-36. PubMed ID: 11164687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of GABA(A) compounds on mCPP drug discrimination in rats.
    Gatch MB; Jung ME; Wallis CJ; Lal H
    Life Sci; 2002 Oct; 71(22):2657-65. PubMed ID: 12354584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and physiological effects of cocaine in humans following triazolam.
    Haga JL; Baker RW; Rush CR
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):383-92. PubMed ID: 14643836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zolpidem generalization and antagonism in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol.
    Helms CM; Rogers LS; Waters CA; Grant KA
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1197-206. PubMed ID: 18482161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.